CLBIO — Corline Biomedical AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK272.93m
- SEK255.46m
- SEK25.03m
- 41
- 11
- 11
- 10
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 22.9 | 8.9 | 41.6 | 26.2 | 17 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.69 | 1.67 | 2.77 | 8.47 | 5.22 |
Prepaid Expenses | |||||
Total Current Assets | 25 | 11 | 44.8 | 36 | 23.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.037 | 0.073 | 0.182 | 0.28 | 0.314 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 63.8 | 58.5 | 102 | 102 | 100 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.43 | 6.24 | 9.43 | 7.19 | 6.79 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 4.43 | 6.24 | 9.43 | 7.19 | 6.79 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 59.3 | 52.2 | 92.2 | 94.6 | 93.3 |
Total Liabilities & Shareholders' Equity | 63.8 | 58.5 | 102 | 102 | 100 |
Total Common Shares Outstanding |